At the Nantz National Alzheimer Center, our lab was the first to link excess tau protein to Alzheimer’s disease brain dysfunction and to map tau progression in dementia, redefining how neurologists approach the illness. We were the first to identify how brain inflammation precedes brain degeneration. We believe our next first will help us find the first truly effective, personalized treatments for those suffering from this devastating disease.
Commemorating the first 10 years of the Nantz National Alzheimer Center and the advances made possible through philanthropic support. Click here to read our 2021 report.
Since its inception in 2011, the Nantz National Alzheimer Center has become a first class, internationally recognized center for the treatment and research of diseases leading to cognitive impairment. Currently, the NNAC has four full‑time neurologists who care for thousands of patients annually. As a result, the NNAC is a leading recruiter among 20 centers involved in an NIH-funded study to research the natural history of early-onset cognitive impairment.
Join Courtney and Jim Nantz in their fight to eradicate the suffering and devastation of Alzheimer’s disease and associated dementia based illnesses. Through philanthropic support, Houston Methodist is applying breakthroughs in neuroimaging toward strategies to better diagnose and potentially prevent or halt the progress of Alzheimer’s disease at its earliest stages.
By joining NantzFriends, you can add your support along with millions of others and join the team that will fight — and win — the battle against the ravages of this disease through world-class research, education and patient care conducted at the Nantz National Alzheimer Center at Houston Methodist.
Houston Methodist Nantz National Alzheimer Center